These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34188210)

  • 1. Advancing on pancreatic cancer.
    Nat Rev Gastroenterol Hepatol; 2021 Jul; 18(7):447. PubMed ID: 34188210
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular landscape of pancreatic cancer: challenges and clinical implications.
    Kyrochristos ID; Ziogas DE; Glantzounis GK; Roukos DH
    Future Oncol; 2017 Dec; 13(30):2741-2744. PubMed ID: 29182377
    [No Abstract]   [Full Text] [Related]  

  • 3. The need for effective pancreatic cancer detection and management: a biomarker-based strategy.
    Crawley AS; O'Kennedy RJ
    Expert Rev Mol Diagn; 2015; 15(10):1339-53. PubMed ID: 26394703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endoscopy in the diagnosis and treatment of cystic pancreatic neoplasms.
    ; Muthusamy VR; Chandrasekhara V; Acosta RD; Bruining DH; Chathadi KV; Eloubeidi MA; Faulx AL; Fonkalsrud L; Gurudu SR; Khashab MA; Kothari S; Lightdale JR; Pasha SF; Saltzman JR; Shaukat A; Wang A; Yang J; Cash BD; DeWitt JM
    Gastrointest Endosc; 2016 Jul; 84(1):1-9. PubMed ID: 27206409
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular subtypes of pancreatic cancer.
    Collisson EA; Bailey P; Chang DK; Biankin AV
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):207-220. PubMed ID: 30718832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms.
    Maker AV; Carrara S; Jamieson NB; Pelaez-Luna M; Lennon AM; Dal Molin M; Scarpa A; Frulloni L; Brugge WR
    J Am Coll Surg; 2015 Feb; 220(2):243-53. PubMed ID: 25592469
    [No Abstract]   [Full Text] [Related]  

  • 8. Treating pancreatic cancer: more antioxidants more problems?
    Alexander MS; Cullen JJ
    Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):849-851. PubMed ID: 29956580
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts.
    Malla RR; Kumari S
    Crit Rev Oncog; 2019; 24(2):119-132. PubMed ID: 31679207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making?
    Ansari D; Aronsson L; Andersson R
    Future Oncol; 2017 Aug; 13(20):1751-1753. PubMed ID: 28831817
    [No Abstract]   [Full Text] [Related]  

  • 11. Detecting and diagnosing ampullary neoplasms.
    Wang LF; Hingorani SR; Tuveson DA
    Cancer Biol Ther; 2004 Jul; 3(7):657-9. PubMed ID: 15326385
    [No Abstract]   [Full Text] [Related]  

  • 12. Caveolin-1: a marker for pancreatic cancer diagnosis.
    Tanase CP
    Expert Rev Mol Diagn; 2008 Jul; 8(4):395-404. PubMed ID: 18598222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for subtypes of pancreatic ductal adenocarcinoma.
    Venkatesan P
    Lancet Oncol; 2017 Dec; 18(12):e718. PubMed ID: 29129444
    [No Abstract]   [Full Text] [Related]  

  • 14. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
    Halbrook CJ; Lyssiotis CA
    Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Pancreatic Cancer.
    Benzel J; Fendrich V
    Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of sporadic pancreatic cancer: strategic map for innovation--a white paper.
    Kenner BJ; Chari ST; Cleeter DF; Go VL
    Pancreas; 2015 Jul; 44(5):686-92. PubMed ID: 25938853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
    Kawaida H; Fujii H
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic cancer: An update on diagnosis and management.
    Loveday BPT; Lipton L; Thomson BN
    Aust J Gen Pract; 2019 Dec; 48(12):826-831. PubMed ID: 31774983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for early pancreatic ductal adenocarcinoma: an urgent call!
    Lee MX; Saif MW
    JOP; 2009 Mar; 10(2):104-8. PubMed ID: 19287101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.